PEOPLE - Changes at Boston Scientific:
This article was originally published in Clinica
Executive Summary
Boston Scientific (Natick, Massachusetts) has elected Guidant directors Kristina Johnson and Nancy-Ann DeParle to its now 14-member board. Ms Johnson, Dean of the Pratt School of Engineering at Duke University, was a co-founder of the Colorado Advanced Technology Institute Center of Excellence in Optoelectronics, and serves on other boards. Ms DeParle, senior advisor for JP Morgan Partners and adjunct professor at the Wharton School of the University of Pennsylvania, previously served as the administrator of the US CMS (then HCFA). Guidant was acquired by Boston last week.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.